NAMS MENOPAUSE CERTIFICATION EXAM
Edition
Actual Real Exam Test Bank with 2 Currently Testing Versions | 100 Questions Each
Total Questions 200 (100 per version, 4 options each)
Versions 2 currently testing versions (V1 + V2), each with 5 sections
Cognitive Mix 25% Recall | 50% Application | 25% Analysis
Question Style 75% scenario-based (patient cases, treatment decisions) | 25% direct
knowledge
Curriculum Aligned with The Menopause Society (formerly NAMS) Certification
Blueprint, STRAW+10 staging, the 2022 NAMS Hormone Therapy
Position Statement, the 2023 NAMS Nonhormone Position Statement,
the 2020 NAMS GSM Position Statement, the 2023 NAMS Early
Menopause Position Statement, the 2024 NAMS/ASRM POI Position
Statement, the 2019 NAMS Testosterone Position Statement, and the
NAMS Osteoporosis and Sexual Health Position Statements
Audience Healthcare professionals preparing for the Menopause Society Certified
Practitioner (MSCP) credential (formerly NCMP)
This practice examination package is independently authored for educational purposes and is not affiliated with,
endorsed by, or sponsored by The Menopause Society (formerly NAMS) or any official testing body. Questions reflect
publicly available NAMS certification blueprint content, NAMS Position Statements (2022 Hormone Therapy, 2023
Nonhormone, 2020 GSM, 2023 Early Menopause, 2024 POI, 2019 Testosterone, Osteoporosis, Sexual Health), the
STRAW+10 staging system, the Women’s Health Initiative (WHI) findings, and current evidence-based clinical
practice guidelines. Candidates should always consult the official NAMS/Menopause Society module materials for the
authoritative scope of their certification examination.
1 Verified Answers — Aligned with The Menopause Society Certification Blueprint Page 1
,NAMS Menopause Certification Exam 2026/2027 — Actual Real Exam Test Bank (2 Versions, 100 Q Each)
Table of Contents
VERSION 1 (Q1–Q100)
Section Topic # Qs Q#
Section 1 Physiology & Pathophysiology of Menopause Transition 19 1
Symptoms & Concerns (VMS, GSM, Sleep, Mood, Cognitive,
Section 2 20 20
Sexual)
Health Disorders in Midlife (Bone, Cardiovascular, Breast,
Section 3 21 40
Thyroid)
Section 4 Treatment Options – Hormonal & Non-Hormonal 16 61
Section 5 Preventive Care & Counseling 24 77
Section 1 Menopause Staging & Reproductive Aging (STRAW+10) 15 101
Menopausal Hormone Therapy (MHT) – Regimens, Dosing,
Section 2 25 116
Risks/Benefits
Section 3 Non-Hormonal & Complementary Therapies 20 141
Section 4 Clinical Assessment & Symptom Management 20 161
Section 5 Special Populations & Comorbidities 20 181
Q1–Q20
TOTAL All Sections Combined (V1 + V2) 200
0
VERSION 2 (Q101–Q200)
Each question presents one correct answer (marked *[CORRECT]*) and includes a 2–4 sentence rationale citing the relevant
The Menopause Society Position Statement, the STRAW+10 staging criteria, or current evidence-based clinical practice
guidelines. Page numbers are automatically maintained by the running header. Q numbering runs sequentially across both
versions.
2 Verified Answers — Aligned with The Menopause Society Certification Blueprint Page 2
,NAMS Menopause Certification Exam 2026/2027 — Actual Real Exam Test Bank (2 Versions, 100 Q Each)
3 Verified Answers — Aligned with The Menopause Society Certification Blueprint Page 3
, NAMS Menopause Certification Exam 2026/2027 — Actual Real Exam Test Bank (2 Versions, 100 Q Each)
VERSION 1
100 Questions — Q1 to Q100
Section 1: Physiology & Pathophysiology of Menopause Transition
Endocrine changes, STRAW+10 staging, AMH/FSH, thermoregulation, POI, early menopause — 19 questions
Q1: A 51-year-old woman reports 9 months of amenorrhea and asks whether she is in menopause. Per
The Menopause Society definition, the clinician's BEST response is:
A. Yes, 6 months of amenorrhea confirms menopause.
B. Menopause is retrospectively diagnosed after 12 consecutive months of amenorrhea not due to
another cause; she should continue contraception until 12 months have passed. *[CORRECT]*
C. Menopause requires two FSH levels above 20 IU/L.
D. Menopause is defined by AMH falling below 0.5 ng/mL.
Correct Answer: B
Rationale: Natural menopause is defined retrospectively as 12 consecutive months of amenorrhea without an alternative
cause (The Menopause Society 2022 Position Statement). FSH and AMH are not required for diagnosis in symptomatic
women aged 45+ but may help when the diagnosis is unclear in younger women. Pregnancy must still be ruled out
(NAMS Position Statement; STRAW+10).
4 Verified Answers — Aligned with The Menopause Society Certification Blueprint Page 4
Edition
Actual Real Exam Test Bank with 2 Currently Testing Versions | 100 Questions Each
Total Questions 200 (100 per version, 4 options each)
Versions 2 currently testing versions (V1 + V2), each with 5 sections
Cognitive Mix 25% Recall | 50% Application | 25% Analysis
Question Style 75% scenario-based (patient cases, treatment decisions) | 25% direct
knowledge
Curriculum Aligned with The Menopause Society (formerly NAMS) Certification
Blueprint, STRAW+10 staging, the 2022 NAMS Hormone Therapy
Position Statement, the 2023 NAMS Nonhormone Position Statement,
the 2020 NAMS GSM Position Statement, the 2023 NAMS Early
Menopause Position Statement, the 2024 NAMS/ASRM POI Position
Statement, the 2019 NAMS Testosterone Position Statement, and the
NAMS Osteoporosis and Sexual Health Position Statements
Audience Healthcare professionals preparing for the Menopause Society Certified
Practitioner (MSCP) credential (formerly NCMP)
This practice examination package is independently authored for educational purposes and is not affiliated with,
endorsed by, or sponsored by The Menopause Society (formerly NAMS) or any official testing body. Questions reflect
publicly available NAMS certification blueprint content, NAMS Position Statements (2022 Hormone Therapy, 2023
Nonhormone, 2020 GSM, 2023 Early Menopause, 2024 POI, 2019 Testosterone, Osteoporosis, Sexual Health), the
STRAW+10 staging system, the Women’s Health Initiative (WHI) findings, and current evidence-based clinical
practice guidelines. Candidates should always consult the official NAMS/Menopause Society module materials for the
authoritative scope of their certification examination.
1 Verified Answers — Aligned with The Menopause Society Certification Blueprint Page 1
,NAMS Menopause Certification Exam 2026/2027 — Actual Real Exam Test Bank (2 Versions, 100 Q Each)
Table of Contents
VERSION 1 (Q1–Q100)
Section Topic # Qs Q#
Section 1 Physiology & Pathophysiology of Menopause Transition 19 1
Symptoms & Concerns (VMS, GSM, Sleep, Mood, Cognitive,
Section 2 20 20
Sexual)
Health Disorders in Midlife (Bone, Cardiovascular, Breast,
Section 3 21 40
Thyroid)
Section 4 Treatment Options – Hormonal & Non-Hormonal 16 61
Section 5 Preventive Care & Counseling 24 77
Section 1 Menopause Staging & Reproductive Aging (STRAW+10) 15 101
Menopausal Hormone Therapy (MHT) – Regimens, Dosing,
Section 2 25 116
Risks/Benefits
Section 3 Non-Hormonal & Complementary Therapies 20 141
Section 4 Clinical Assessment & Symptom Management 20 161
Section 5 Special Populations & Comorbidities 20 181
Q1–Q20
TOTAL All Sections Combined (V1 + V2) 200
0
VERSION 2 (Q101–Q200)
Each question presents one correct answer (marked *[CORRECT]*) and includes a 2–4 sentence rationale citing the relevant
The Menopause Society Position Statement, the STRAW+10 staging criteria, or current evidence-based clinical practice
guidelines. Page numbers are automatically maintained by the running header. Q numbering runs sequentially across both
versions.
2 Verified Answers — Aligned with The Menopause Society Certification Blueprint Page 2
,NAMS Menopause Certification Exam 2026/2027 — Actual Real Exam Test Bank (2 Versions, 100 Q Each)
3 Verified Answers — Aligned with The Menopause Society Certification Blueprint Page 3
, NAMS Menopause Certification Exam 2026/2027 — Actual Real Exam Test Bank (2 Versions, 100 Q Each)
VERSION 1
100 Questions — Q1 to Q100
Section 1: Physiology & Pathophysiology of Menopause Transition
Endocrine changes, STRAW+10 staging, AMH/FSH, thermoregulation, POI, early menopause — 19 questions
Q1: A 51-year-old woman reports 9 months of amenorrhea and asks whether she is in menopause. Per
The Menopause Society definition, the clinician's BEST response is:
A. Yes, 6 months of amenorrhea confirms menopause.
B. Menopause is retrospectively diagnosed after 12 consecutive months of amenorrhea not due to
another cause; she should continue contraception until 12 months have passed. *[CORRECT]*
C. Menopause requires two FSH levels above 20 IU/L.
D. Menopause is defined by AMH falling below 0.5 ng/mL.
Correct Answer: B
Rationale: Natural menopause is defined retrospectively as 12 consecutive months of amenorrhea without an alternative
cause (The Menopause Society 2022 Position Statement). FSH and AMH are not required for diagnosis in symptomatic
women aged 45+ but may help when the diagnosis is unclear in younger women. Pregnancy must still be ruled out
(NAMS Position Statement; STRAW+10).
4 Verified Answers — Aligned with The Menopause Society Certification Blueprint Page 4
